chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered pharmacist (R.Ph.) concerning an 80 year old female patient. The patient's pertinent medical history and drug reactions or allergies were unknown. On 01-AUG-2012, the patient was vaccinated with a dose of ZOSTAVAX (dose, route and frequency were not reported) (lot # and expiration date were not reported). The pharmacist reported that on an unknown date, the patient developed inflammation following vaccination with ZOSTAVAX. The patient was given MEDROL DOSE PACK as treatment for the event. The patient sought medical attention by contacting the physician. There was no intervention to prevent serious criteria. At the time of the report, the patient had not recovered from the inflammation following vaccination. Additional information has been requested.
Patient with 2 Pfizer COVID vaccinations, last dose 05/05/21, who admitted with ischemic stroke who incidentally tested detected for COVID during admission testing.  No s/s of COVID per provider d/c note during stay.  Provider d/c note below:  "Patient is a 61 YO female who was admitted for ischemic stroke of anterior right parietal associated with L occipital subacute intraparenchymal hemorrhage. Patient was also found to have COVID 19, asymptomatic. Neurosurgery and neurology were consulted. Her repeat CT scan to monitor hemorrhage was stable and per neurosurgery no need to hold DAPT so they were resumed. She was started on high dose statin. Ordered cardiac event monitor to monitor for any cardiac arrhythmias leading to stroke. Patient will referred to vascular neurology."
Facial swelling, Paresthesia to palms of hands bilaterally, Headache, Malaise. Treatment: 40MG Prednisone qd x 3days and 50mg Benadryl po q 6 hours x 1 day. Follow up in 09/08/2011
4x2" Rash at Injection site went away in a few days, Headaches, Fatigue, aches mainly upper body for 2 weeks, sensation of throat trying to close at times
After receiving HPV and HepA vaccines patient became pale and "everything looked black." Patient had a syncopal episode for a few seconds.
The patient got both vaccines around 8:35 and did well. 3-5 minutes later she was in the waiting room and started feeling nauseous and was having trouble seeing/dizzy. She then threw up. After she threw up she began feeling better quickly. She was able to drink juice and eat a granola bar. Denies itching, throat swelling, difficulty breathing, or any other symptoms. BP was WNL. After she and her father stuck around for another 20 minutes she was feeling fine and they left.
This case was reported by a pharmacist via call center representative and described the occurrence of arthralgia in a 51-year-old female patient who received RABAVERT. Concomitant products included RABAVERT. On 29th August 2016, the patient received the 2nd dose of RABAVERT. On 29th August 2016, less than a day after receiving RABAVERT, the patient experienced arthralgia. On an unknown date, the outcome of the arthralgia was not recovered/not resolved. It was unknown if the reporter considered the arthralgia to be related to RABAVERT. Additional details were provided as follows: On 26th August 2016, the patient received 1st dose of RABAVERT in post exposure series. After receiving 2nd dose of RABAVERT the patient developed arthralgia in the shoulders and hips. On 2nd September 2016, the patient received 3rd dose of RABAVERT. On 9th September2016, the patient received 4th dose of RABAVERT. The reporter did not have vaccine lot and expiration date.
SORENESS ON INJECTION SITE ARM; This spontaneous report received from a patient concerned a 64 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included arthritis in hip, and smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced soreness on injection site arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from soreness on injection site arm. This report was non-serious.
Itching/redness at site and nausea. Pt request report as she has had persisting itching and recurring viral URI since vaccine. No antibiotics. Pt refuses rx. Only wants dietary supplement.
This spontaneous report was received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patients' medical history and concurrent conditions were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX lot # L013068, expiration date: 14-APR-2017 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 18 degrees Fahrenheit for 36 minutes. Data logger was involved. There were no previous excursions reported. Concomitant medications were not reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from Medical Assistant refers to a unspecified number of patients of unknown age and gender. On an unknown date in 2014 the patients were vaccinated with ZOSTAVAX (dose, route and administration and indication were not provided). It was reported that the patients received doses of ZOSTAVAX that underwent supported temperature excursions. Doses were administered between the dates of 26-AUG-2014 through 29-OCT-2014. No adverse experiences reported. This is one of several reports received from the same source. Additional information has been requested.
High fever and chills. Chills and fever lasted about 5-6 hrs. Took shot on Friday, arm got blue and sore. Next day, got a big knot below the blue spot. Had extreme pains every night for 5 days. Had to go to doctor.
Numbness/tingling she describes as "spider-web" like sensations down both arms and legs.; Numbness/tingling she describes as "spider-web" like sensations down both arms and legs.; Soreness in arm; This is a spontaneous report from a non-contactable healthcare professional. A 68-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) via intramuscular route of administration in the right arm on 11Sep2021 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date in Sep2021, the patient experienced normal soreness in arm for a couple days that went away but, on 15Sep2021, the patient was having numbness/tingling described as "spider-web" like sensations down both arms and legs. The clinical outcome of the event soreness in arm was resolved on an unknown date in Sep2021. The clinical outcome of the events numbness/tingling described as "spider-web" like sensations was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Trouble walking due to the swollen inflammation on my foot.; Trouble walking due to the swollen inflammation on my foot.; Trouble walking due to the swollen inflammation on my foot.; Pain on the bottom of my feet/Pain on fingers; Pain on knee; Migraine headache; Chills; Fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine headache), GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.), PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers) and INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and APIXABAN (ELIQUIS) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced MIGRAINE (migraine headache), CHILLS (chills), PYREXIA (Fever) and NAUSEA (Nausea). On 11-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers) and ARTHRALGIA (Pain on knee). On an unknown date, the patient experienced GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.) and INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.). At the time of the report, MIGRAINE (migraine headache), GAIT DISTURBANCE (Trouble walking due to the swollen inflammation on my foot.), PERIPHERAL SWELLING (Trouble walking due to the swollen inflammation on my foot.), PAIN IN EXTREMITY (Pain on the bottom of my feet/Pain on fingers), INFLAMMATION (Trouble walking due to the swollen inflammation on my foot.), CHILLS (chills), PYREXIA (Fever), NAUSEA (Nausea) and ARTHRALGIA (Pain on knee) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Fibrin D dimer: high (High) too high.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient went to doctor and was told to take Eliquis.  Action taken with mRNA-1273 in response to the event was not applicable .   This case was linked to MOD-2021-238916 (Patient Link).
no adverse event; multiple patients were vaccinated with an improperly stored vaccine; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On16-MAY-2019, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 2 ml, orally (lot # R034700, expiry date 16-JUN-2020) for prophylaxis. The vaccine was exposed to a temperature of 34.2 Fahrenheit degrees for 4 hours and 54 minutes. Digital data logger was involved. There were no previous temperature excursions. No adverse effects were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011674: US-009507513-1907USA000862: US-009507513-1907USA000882: US-009507513-1907USA000883: US-009507513-1907USA000884: US-009507513-1907USA000885: US-009507513-1907USA000886: US-009507513-1907USA000887: US-009507513-1907USA000888: US-009507513-1907USA000889: US-009507513-1907USA000890: US-009507513-1907USA000891: US-009507513-1907USA000892: US-009507513-1907USA000893: US-009507513-1907USA000894: US-009507513-1907USA000895: US-009507513-1907USA000896: US-009507513-1907USA000897: US-009507513-1907USA000899: US-009507513-1907USA000900: US-009507513-1907USA000901: US-009507513-1907USA000902: US-009507513-1907USA000903: US-009507513-1907USA000904: US-009507513-1907USA000905: US-009507513-1907USA000906: US-009507513-1907USA000907: US-009507513-1907USA000908: US-009507513-1907USA000909: US-009507513-1907USA000910: US-009507513-1907USA000911: US-009507513-1907USA000912: US-009507513-1907USA000913: US-009507513-1907USA000914: US-009507513-1907USA000915: US-009507513-1907USA000916: US-009507513-1907USA000917: US-009507513-1907USA000918: US-009507513-1907USA000919: US-009507513-1907USA000920: US-009507513-1907USA000921: US-009507513-1907USA000922: US-009507513-1907USA000923: US-009507513-1907USA000924: US-009507513-1907USA000925: US-009507513-1907USA000926: US-009507513-1907USA000927: US-009507513-1907USA000928: US-009507513-1907USA000929: US-009507513-1907USA000930: US-009507513-1907USA000931: US-009507513-1907USA000932: US-009507513-1907USA000933: US-009507513-1907USA000934: US-009507513-1907USA000935: US-009507513-1907USA000936: US-009507513-1907USA000937: US-009507513-1907USA000938:
At around 8pm, this would be 1.5 hours after receiving the vaccine; I felt shortness of breath and my chest hurt in the front and my back.  It felt like my heart was expanded and I felt pressure on my chest. I continued to feel this symptoms for the next 3 days after the vaccine, I don't feel chest pressure but I continue to feel shortness of breath and this has discouraged me from taking the second dose. My daughter (12 years old) took the vaccince at the same time as me and has felt similar symptoms. I will submit a report for her as well. We have not gone to the doctor for the adverse event as we have no medical insurance.
Patient received the first dose of COVID-19 Moderna vaccine, then came up to the pharmacy counter several minutes later stating he felt lightheaded and thought he might pass-out. He was instructed to have a seat until he was feeling ok. As he turned, he fell to the floor slowly and we immediately called 911. Upon getting to the patient in our waiting area, he was already alert. He was instructed to stay down. He sat himself up  and stayed on the floor. He requested water, so we got him a bottle of water. He remained on the floor for a few minutes then made his way to a chair a few feet away. He stated he hadn't eaten much today, so we offered something to eat but he refused. EMS arrived and spoke to him about how he was feeling. EMS took his blood pressure seated and standing and asked if he would like to go to the hospital but the patient refused.  EMS eventually left and the patient remained seated for 15-20 minutes. We checked in on him, asking if he needed anything and about how he was feeling.  He stated he was starting to feel better. He made some phone calls, presumably for a ride, and ultimately left the pharmacy without notifying anyone.
Shingle-like response; Tinnitus; This is a spontaneous report received from a contactable consumer. This consumer (patient) reported for herself.  A female patient of unspecified age received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: ER8733, Expiration date: unknown), via unspecified route, administered in left arm on 26Mar2021 15:30 as dose 1, single for COVID-19 immunization. The patient medical history includes Seasonal allergy and Colitis ulcerative both from an unknown onset and ongoing and concomitant medications includes Fluticasone Propionate and Cetirizine Hydrochloride (ZYRTEC ALLERGY). On 26Mar2021, after the vaccination, the patient experienced reported tinnitus and shingle-like response after being administered that first dose of Pfizer Covid Shot. She already reported this to the  VAERS site or whatever but has not reported this to Pfizer previously. She is still experiencing this. Described as a ringing in her ear non-stop. She is assuming it is Meniere's disease; but it is a buzz in her head. It is hard to distinguish whether it is in her head or ears, but she thinks it is probably ears. It was sudden onset particularly when they gave her the Pfizer Covid Shot. She went to sit in that area that they wait in it was severe at that time worse at that time, but it is still ongoing. She does not plan to get the second dose of the Pfizer Covid Shot due to this event. She wanted to get the shot for shingles, but she had to wait. She mentioned that the Pfizer Covid Shot produced a shingle-like response in her system like a shingles rash that lasted like a week which terrified her. She still needs to get the shingles shots. She can't say 100% that event was shingles, but it looked very close to shingles; the rash itched and burned like nothing she has ever felt in her life. According to her brother who had shingles that's what his shingles felt like when he had shingles. Shingle-like response started probably like a week and a half after she was administered Pfizer Covid Shot. No other vaccines were taken four weeks Prior to vaccination. The outcome of the event tinnitus was recovering and herpes zoster was unknown.  No follow-up attempts possible. No further information expected.
Chills ,fever, generalized headache, dizziness, nausea and emesis went to Emergency room 12 hours after vaccine given. Got labs, IV fluids, ZOFRAN and sent home. VS P106 BP 103/59,T100.6 RR18.
Pt was given the liquid conjugate component (CYW-135)  (vial 1) of the two vials that should have been given. Vial two containing the A conjugate was not reconstituted and given.  Office called GSK for further guidance.
Patient stood up after getting the vaccine. He was not coordinated, said he was dizzy, and about to faint. He was guided back to a chair, and monitored. After a long time, he said, he was back to normal .
After getting the vaccine I experienced loose stools and a sore arm. Otherwise, I didn't experience any other adverse reactions. On December 15th I experienced sniffles. On December 16th I had a runny nose, a sore throat, and a cough. On December 17th I had a sore throat, coughing and more phlegm. On December 19th I was coughing more with phlegm. I felt like I had a bad cold. On December 20th I went to the doctor because I was still coughing.  I was diagnosed with pneumonia. I was prescribed Azithromycin 250mg, Levofloxacin 500mg, and Virtussin cough syrup. On December 22nd I seen my doctor. I was told that my oxygen levels were low. I was prescribed an Albuterol inhaler. From December 22nd to 25th I was coughing a lot. On December 27th it started to subside. I wasn't as congested anymore. I'm still coughing with phlegm and have congestion, but it has gotten better because I don't cough as much.
This case was reported by a pharmacist via call center representative and described the occurrence of red blotches in a 70-year-old female patient who received SHINGRIX (batch number 32GR4, expiry date unknown) for prophylaxis. Concomitant products included RESTASIS, Losartan, TRAVATAN and hydrochlorothiazide. On 13th June 2018, the patient received the 1st dose of SHINGRIX. In June 2018, less than a week after receiving SHINGRIX, the patient experienced red blotches. On an unknown date, the outcome of the red blotches was unchanged. It was unknown if the reporter considered the red blotches to be related to SHINGRIX. Additional details were provided as follows: The age at the time of vaccination could be 70 years or 69 years. The age at vaccination was not reported. The patient received SHINGRIX vaccine on left arm. The patient reported blotchy redness with uneven borders after receiving SHINGRIX. The exact time of onset was unknown. The pharmacist did not have other patient information or expiration date at time of call.
Same as I had when I had Covid-19 seven months previously:  extreme fatigue and total loss of appetite, but this time it lasted only 13 hours instead of 10 days or more.  I tested positive for Covid-19 antibodies 2 weeks prior to the shot.
This spontaneous report was received from a nurse referring to 4 patients of unknown age and gender. The patients' pertinent medical history, current conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored dose of ROTATEQ lot # M006112 for prophylaxis. The vaccine was exposed to temperature of 49 Fahrenheit for 30 minutes. No previous temperature excursion was reported. No adverse effects and no product quality complaint (PQC) was reported. No further information provided. Follow up information has been received on 22-NOV-2016, than all telephone attempts to obtain follow-up information have been unsuccessful. Follow up information has been received from the nurse on 06-DEC-2016, who stated that the 6 months old patient of unknown gender was vaccinated on 20-OCT-2016 with a dose of ROTATEQ orally (volume/dose reported as 2). This is one of several reports from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1610USA004378: US-009507513-1610USA004376: US-009507513-1610USA004377: US-009507513-1612USA006676: US-009507513-1612USA006673: US-009507513-1612USA006675: US-009507513-1612USA006674: US-009507513-1612USA006672:, MERCK 1610USA003097:Mfr number.
swelling, redness, itching, and warmth of entire forearm after administration of influenza vaccine and dT vaccine. No fever or other systemic signs.
chills; headache; nausea; vomiting; diarrhea; throwing up all night; eaten little; felt like exposed to COVID; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting) and DIARRHOEA (diarrhea) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gastro-intestinal disorder NOS.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced CHILLS (chills), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea), VOMITING (throwing up all night), DECREASED APPETITE (eaten little) and EXPOSURE TO SARS-COV-2 (felt like exposed to COVID). At the time of the report, CHILLS (chills), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea), VOMITING (throwing up all night), DECREASED APPETITE (eaten little) and EXPOSURE TO SARS-COV-2 (felt like exposed to COVID) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Brief loss of consciousness and jerking movements lasting about 15 seconds. Then patient became responsive. Patient received O2, MD conducted neuro exam which was normal and obtained finger stick blood glucose which was normal. Patient was sent home. Gardasil was added to allergy list. This was the patient's second dose of HPV vaccine. She tolerated the first dose well.
03/06/2006 patient received varicella and td vaccine.  03/25/2006 patient noticed red swollen bump to right neck.  On 03/27/2006 patient woke up with multiple macular and vesicular lesions to chest, arms, legs, and face.
I experienced itchiness on my right arm during the first week after my second shot but did not look to see if there was the large red area that is pictured online. However, on the eighth day, I reached over to touché my arm and felt many bumps. I looked in the mirror at my right arm and saw a rash consisting of many large, red bumps. They did not hurt, they were not itchy.  They have been very slow to resolve.  Now, after eight days, the bumps while still visible are finally beginning to fade. I have daily photographs of my rash if you?d like to see them.